文献速递妇科

患者自主启动随访对复发恐惧及医疗资源使用的影响:早期子宫内膜癌随机试验

Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer.
PubMed 文献 · BJOG · 2018-08-06

在丹麦四个妇科科室开展的多中心随机试验,纳入156例FIGO I期低中危子宫内膜癌患者,比较患者自主启动随访与医院常规随访。主要终点为10个月时复发恐惧量表(FCRI)评分,结果显示对照组复发恐惧下降显著更多(差值-5.9,95%CI -10.9至-0.9);干预组科室检查次数更少(中位数0次 vs 2次,P<0.01)。作者认为患者自主启动随访可行且可能降低费用,但应权衡利弊。

要点

  • 医院常规随访较患者自主启动随访在10个月时FCRI评分下降更多(差值-5.9,95%CI -10.9至-0.9)。
  • 干预组科室检查中位0次 vs 对照组2次(P<0.01),其中58%的检查因阴道出血安排。
  • 患者自主启动随访可行且可能降低费用,但应权衡获益与风险。

核心结论

  • 医院常规随访较患者自主启动随访显著更多减轻复发恐惧,但估计差异较小。
  • 患者自主启动随访在复发风险低的子宫内膜癌生存者中可行且可能降低费用,决策应权衡获益与风险。

研究设计与样本

  • 实用型多中心随机试验,2013年5月至2016年5月在丹麦四个妇科科室开展。
  • 纳入156例FIGO I期低中危子宫内膜癌女性。
  • 对照组接受医院常规随访(初级治疗后3年定期门诊);干预组接受患者自主启动随访(详细警报症状指导与自我转诊选项,而非固定检查计划)。

主要发现

  • 主要分析中,对照组从基线至随访10个月FCRI评分下降显著更多(差值-5.9,95%CI -10.9至-0.9)。
  • 大部分改善仅在随访3个月后发生。
  • 干预组科室检查次数少于对照组(中位数0次 vs 2次,P<0.01),其中58%的检查因阴道出血安排。

关键数值与推荐

  • 主要终点为随访10个月时以复发恐惧量表(FCRI)测量的复发恐惧。
  • 次要终点包括治疗后的前10个月内癌症相关初级和二级医疗使用。

临床怎么用

  • 作者认为患者自主启动随访是可行且可能降低费用的随访方式,适用于复发风险低的子宫内膜癌生存者。
  • 作者认为使用患者自主启动随访的决定应权衡这些获益与风险。
  • 未来需进行生活质量与成本效果分析以权衡患者自主启动随访的获益与风险。

局限性

  • 自我转诊组参与者知道自己接受的检查少于其他女性,这可能诱发复发恐惧。
  • 定期完成复发恐惧问卷可能提醒女性疾病,从而缩小两组间差异。
  • 未来需进行生活质量与成本效果分析以权衡患者自主启动随访的获益与风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that patient-initiated follow up reduces the fear of cancer recurrence (FCR) and healthcare use when compared with traditional hospital-based follow up. DESIGN: Pragmatic, multicentre randomised trial. SETTING: Four Danish departments of gynaecology between May 2013 and May 2016. POPULATION: One hundred and fifty-six women diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage I low-intermediate risk endometrial carcinoma. METHODS: Women allocated to the control group attended hospital-based follow up consisting of regular outpatient visits for 3 years after primary treatment. Women in the intervention group were instructed in patient-initiated follow up, which included careful instruction in alarm symptoms and options for self-referral rather than a schedule of examinations. MAIN OUTCOME MEASURES: The primary end point was FCR as measured by the Fear of Cancer Recurrence Inventory (FCRI) after 10 months of follow up. Secondary end points included cancer-related use of primary and secondary health care during the first 10 months after treatment. RESULTS: In the primary analysis, FCR decreased significantly more in the control group from baseline to 10 months of follow up (difference -5.9, 95% CI -10.9 to -0.9). The majority of this improvement happened after only 3 months of follow up. Women receiving the intervention had fewer examinations at the department compared with the control group (0 versus 2 median visits, P < 0.01) and 58% of these examinations were scheduled because of vaginal bleeding. CONCLUSIONS: Hospital-based follow up alleviates FCR significantly more than patient-initiated follow up, though the estimated difference was small. Patient-initiated follow up is a feasible, potentially cost-reducing follow-up approach in a population of endometrial cancer survivors with low risk of recurrence. The decision to use patient-initiated follow up should balance these benefits and harms. TWEETABLE ABSTRACT: Patient-initiated follow up reduces healthcare use but maintains fear of recurrence in endometrial cancer. PLAIN LANGUAGE SUMMARY: Why and how was the study carried out? Follow up of women with endometrial cancer is resource consuming and previous research suggests that it is not effective. Even though the women benefit from reassurance at follow up, routine examinations may also remind the women of the disease and induce fear of cancer recurrence. Furthermore, routine follow up may delay recurrence diagnosis, because the women do not report their symptoms until the next scheduled visit. In the research explained in this article, patient-initiated follow up was evaluated as an alternative to traditional follow up. The women were randomly assigned to one of two follow-up programmes: regular gynaecological examinations at the department of gynaecology or self-referral with careful instruction in alarm symptoms, that is, patient-initiated follow up. The level of fear of cancer recurrence in the two groups was obtained by questionnaires. Information on healthcare use was obtained by questionnaires and a chart review. What were the main findings? Regular examinations at the department of gynaecology reduced the fear of cancer recurrence significantly more than patient-initiated follow up, though the difference was small. Women who were instructed in alarm symptoms, under self-referral, were able to monitor their symptoms, and this approach significantly reduced the number of examinations at the department of gynaecology. What are the limitations of the work? Participants in the self-referral group knew that they were examined less than other women, and this may have induced fear of cancer recurrence. Similarly, the regular completion of questionnaires regarding fear of cancer recurrence may have reminded the women of the disease and diminished the difference between the two groups. What are the implications for patients Patient-initiated follow up reduced healthcare use but maintained fear of cancer recurrence in women who had survived early-stage endometrial cancer. Future analyses on quality of life and cost-effectiveness are needed to balance the benefits and harms of patient-initiated follow up.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Jeppesen MM, Jensen PT, Hansen DG, et al. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer. BJOG. 2018. PMID: 29978593. doi:10.1111/1471-0528.15396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。